To the best of the authors' knowledge, no previous study has compared the prevalences of Chlamydia trachomatis (CT) or Neisseria gonorrhoeae (NG) cervical infection among pregnant and non-pregnant patients presenting to the emergency department (ED) with vaginal bleeding. Objectives: To determine the prevalence of these infections in a simultaneously assembled cohort, and to determine whether pregnancy is associated with altered rates of CT or NG cervical infection among patients with vaginal bleeding. Methods: This was a prospective, seven-month, cross-sectional study of a convenience sample of patients (aged Ն 15 years) who presented to an urban, teaching ED with the chief complaint of vaginal bleeding. A urine pregnancy test was administered to each patient. Cervical swab specimens were analyzed for CT or NG via polymerase chain reaction technology (DNA probe). The hospital laboratory's baseline 18% rate of positive tests was used for sample size planning. Chisquare analysis and Fisher's exact test, where appropriate, were used to compare pregnant and non-pregnant patient groups. Results: Cervical infection rates did not differ between pregnant and non-pregnant patients. Testing for CT showed that 13 of 114 (11%) of the pregnant patients were positive, while 11 of 147 (8%) non-pregnant patients tested positive ( 2 = 0.759, p = 0.384). Testing for NG revealed that seven of 114 (6%) pregnant patients tested positive, while 16 of 147 (11%) non-pregnant patients tested positive ( 2 = 1.256, p = 0.262). Combined testing showed that 18 of 114 (16%) of the pregnant patients and 25 of 147 (17%) of the non-pregnant patients harbored a cervical infection with one or both pathogens ( 2 = 0.009, p = 0.925). Conclusions: The prevalence of CT or NG cervical infection in pregnant patients presenting to the ED with vaginal bleeding is 16%. Pregnant and non-pregnant patients with vaginal bleeding are at similar risks for having CT or NG cervical infection. Cervical swab specimens should be obtained in all patients with vaginal bleeding.
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Vaginal bleeding is a common chief complaint among female patients presenting to the emergency department (ED). Although dysfunctional uterine bleeding and threatened abortion are common discharge diagnoses in non-pregnant and pregnant women with vaginal bleeding, respectively, this symptom may be the presenting complaint of myriad other diagnoses. One such diagnosis with the potential for serious sequelae is cervical infection. [1] [2] [3] Sexually transmitted diseases contribute to more serious pathology such as pelvic inflammatory dis-ease, tubo-ovarian abscesses, ectopic pregnancies, infertility, and chronic pelvic pain. [4] [5] [6] Fetal morbidity and mortality may also result from maternal genital tract infection leading to preterm labor and delivery, as well as neonatal conjunctivitis and pneumonia. 7, 8 Cervical infection caused by Chlamydia trachomatis and Neisseria gonorrhoeae is at the forefront of this epidemic because it is the starting point for ascending female genital tract infection. 9, 10 Physiologic changes associated with the latter part of pregnancy are commonly thought to confer protection against pelvic inflammatory disease. The cervical mucous plug, fetal membranes, and decidua limit ascending infection from the cervix. [11] [12] [13] [14] [15] To the best of our knowledge, no previous study has compared the prevalences of cervical infection in pregnant and non-pregnant women presenting to the ED for vaginal bleeding. The objective of this study was to compare the prevalences of C. trachomatis or N. gonorrhoeae cervical infection in women less than 20 weeks pregnant and non-pregnant women presenting to the ED with a chief complaint of vaginal bleeding.
METHODS
Study Design. This prospective, cross-sectional, observational study entered a convenience sample of patients presenting to an urban ED with the chief complaint of vaginal bleeding. Patients were enrolled during a seven-month period extending from April 1, 2000, through October 31, 2000. Patients presenting multiple times for vaginal bleeding were entered only once in the study, corresponding with the initial presentation during the study period. The institutional review board approved the study protocol and waived the need for written informed consent.
Study Setting and Population. The setting for this study was an urban, university ED with an annual census of approximately 53,000 patients. The majority of patients served were African American, with a smaller proportion of European American, Hispanic, and Asian patients. The participating ED treated adults and emancipated minors, including pregnant adolescents. Inclusion criteria for enrollment in this study were: 1) presentation to the ED with the chief complaint of vaginal bleeding; 2) age Ն 15 years; 3) not pregnant or less than 20 weeks pregnant as determined by history, urine pregnancy test, and clinical examination; and 4) consent to undergo a urine pregnancy test and pelvic examination with the collection of an endocervical swab. Patients were considered to be less than 20 weeks pregnant if the urine pregnancy test was positive and the uterine fundus was not palpable superior to the umbilicus. Less than 20 weeks' gestation, without defining pregnancy trimester, was chosen as the inclusion cutoff because, at this institution, pregnant patients of more than 20 weeks' gestation are evaluated primarily by the obstetrical service in the labor and delivery area, rather than in the ED. No specific exclusion criteria were used other than the limitations placed on study enrollment by the inclusion criteria. However, eligibility was not restricted by the presence of concurrent symptoms.
Study Protocol. Emergency physicians, including second-and third-year emergency medicine residents, collected clinical information on the subjects as part of the routine patient evaluation. All the physicians had been previously informed of the nature of the study, and the need to obtain a urine pregnancy test and an endocervical specimen for DNA analysis from all study participants. They were instructed on the proper technique for obtaining the endocervical specimen and completion of the informational data form documenting aspects of the history, physical examination, and laboratory evaluation. Patient enrollment was dependent on the evaluating physician's completing the informational data form and the patient's agreeing to the routine evaluation. Patients were enrolled regardless of the time of day. Treatment of the patients was not affected by the study, and the endocervical specimens were obtained as part of the routine care of the patient. The study investigators later reviewed and recorded the DNA analysis results of the endocervical swab specimen. Patients with a positive endocervical specimen who had not received appropriate antibiotic therapy were contacted and treated as per hospital protocol.
Measurements. Each woman was administered a urine qualitative pregnancy test and underwent a speculum examination to obtain an endocervical swab specimen for testing using chlamydial and gonococcal DNA polymerase chain reaction (PCR) gene amplification technology (Gen-Probe, San Diego, CA). The results of each of these tests were recorded as either ''positive'' or ''negative.'' Only nominal data were recorded and analyzed.
Data Analysis. The patients were grouped as ''pregnant'' or ''not pregnant'' based on the results of the urine qualitative pregnancy test and clinical examination. No differentiation was made in the ''pregnant'' group between first-and second-trimester pregnancies. Sample size planning for this study was based on an overall 18% positive rate for cervical swabs analyzed by the hospital's laboratory for C. trachomatis and N. gonorrhoeae. A ''positive'' value was defined as the presence of DNA from either or both of these pathogens on an endocervical swab specimen.
The purpose of this study was to describe the prevalence of infection with C. trachomatis or N. gonorrhoeae in pregnant and non-pregnant patients. The goal was to study enough patients such that the width of the 95% confidence interval (95% CI) would be Ϯ5% of the calculated proportion value. Using the hospital laboratory's historical rate of approximately 20% positive tests for C. trachomatis or N. gonorrhoeae for ''p,'' the approximate confidence interval can be quantified as
. Using 1.96 as the appropriate value for Z for a 95% CI, a minimum of 246 patients would be required for ''n.'' 16 The number and percentage of participants in each group with a positive C. trachomatis, N. gonorrhoeae, or C. trachomatis and N. gonorrhoeae endocervical specimen were determined, and 95% CIs were calculated. Chi-square (
2 ) analysis and Fisher's exact test, where appropriate, were used to compare study groups, with p < 0.05 being significant.
RESULTS
Data for a total of 261 patients were analyzed after excluding 32 patients for a repeat ED visit or a lack of collection of an endocervical specimen by the physician. In the pregnant group, 11 visits were excluded as repeat visits, and seven visits were excluded for lacking an endocervical swab. In the non-pregnant group, six visits were excluded as repeat visits, and eight visits were excluded for lacking an endocervical swab. After the exclusions, 114 (44%) pregnant subjects and 147 (56%) non-pregnant subjects remained. A total of 43 of 261 (16%) women tested positive for one or both pathogens from the endocervical swab. Four patients, two in each study group, tested positive for both pathogens. During the study period, 459 different patients were found to present to this ED complaining of ''vaginal bleeding, threatened abortion, or possible miscarriage,'' yielding a 57% (261/459) patient capture rate. Table 1 demonstrates that the ''pregnant'' and ''non-pregnant'' study groups did not differ significantly in their clinical presentations. Testing for C. trachomatis showed that 13 of 114 (11%; 95% CI = 7% to 19%) of the pregnant participants tested positive, while 11 of 147 (8%; 95% CI = 4% to 16%) of the participants who were not pregnant tested positive ( 2 = 0.759, p = 0.384). Specimens tested for N. gonorrhoeae revealed that seven of 114 (6%; 95% CI = 3% to 13%) of the pregnant participants were infected with this pathogen. Of the participants who were not pregnant, 16 of 147 (11%; 95% CI = 7% to 18%) had a positive endocervical specimen for N. gonorrhoeae ( 2 = 1.256, p = 0.262).
The total numbers of patients in the pregnant and non-pregnant groups with one or both infections were assessed, given that the current standard of care is to treat all cases of cervical infection for both pathogens. 17 In the group of pregnant subjects, 18 of 114 (16%; 95% CI = 11% to 26%) tested positive for either or both C. trachomatis and N. gonorrhoeae, while 25 of 147 (17%; 95% CI = 12% to 24%) nonpregnant subjects tested positive for one or both of these cervical pathogens ( 2 = 0.009, p = 0.925). Table 2 depicts these results.
Finally, the clinical characteristics of those individuals testing positive for a cervical pathogen in each of the two patient groups were compared using Fisher's exact test. Two characteristics were found to be statistically significant, although delineating clinical predictors of cervical infection was not a goal of the study. During the historical evaluation, affirmation by the patient of the presence of an abnormal vaginal discharge was significantly more common in pregnant patients (39%) who had proven cervical infection compared with non-pregnant patients (2%) who had proven cervical infection (p = 0.023). During the physical examination, non-pregnant patients (76%) who had proven cervical infection were significantly more likely to have blood identified at the cervical os compared with pregnant patients (28%) who had proven cervical infection (p = 0.002). The other characteristics listed in Table 3 did not differ significantly.
DISCUSSION
The protective effect of pregnancy in the second and third trimesters against ascending genital tract infection, specifically pelvic inflammatory disease, has been explained in the past by describing the cervical mucous plug, fetal membranes, and decidua of pregnancy as functioning as a mechanical barrier against ascending infection from the cervix. [11] [12] [13] [14] [15] To the best of our knowledge, no previous study has attempted to determine whether there might be any protective or predisposing effect of pregnancy as it relates to cervical infection.
Several previous studies have looked at the relationship between of states of elevated levels of estrogen and progesterone and C. trachomatis infections. Tuffrey and Taylor-Robinson showed the survival of C. trachomatis to be enhanced by estrogen and progesterone in the female mouse genital tract. 18 Further, human studies have shown that women using oral contraceptives have increased recovery of C. trachomatis from the cervix, possibly relating to increased cervical ectropion caused by the oral contraceptives. 1, 19, 20 The high levels of progesterone during pregnancy could potentially have a similar effect on the cervix, predisposing to chlamydial infection.
These data suggest that the first 20 weeks of pregnancy do not protect against cervical infection or predispose to cervical infection, given that the prevalences of pathogen recovery in the pregnant and non-pregnant study groups were not significantly different. The main implication of these findings is that screening for sexually transmitted diseases should routinely take place in all women presenting to the ED for vaginal bleeding, regardless of pregnancy status, if they are part of a population with a high background rate of cervical infection. Appropriate antibiotic treatment for symptomatic cervical infection should be initiated in the ED at the time of endocervical specimen collection. Alternatively, antibiotics may be administered at a follow-up appointment with the patient's primary care physician in the days following the ED evaluation, if the patient is found to have an occult cervical infection based on endocervical swab results.
LIMITATIONS
One limitation of this study was that all patients were assumed to be sexually active and, consequently, at risk of contracting a sexually transmitted disease. The pregnant patients were obviously known to be sexually active. However, the patients who were not pregnant were not asked about sexual activity. If these study participants were not sexually active, they would not be at risk of cervical infection. This could decrease the apparent prevalence of cervical infection in non-pregnant patients. If a sizable number of the non-pregnant patients were not sexually active, the estimated infection rate in non-pregnant patients may be understated, and the prevalence of cervical infection in pregnant patients may have been significantly less than in non-pregnant patients in this study.
Another limitation of this study is the eligible patient capture percentage of 57%. Although patients were enrolled at all times of the day for a sevenmonth period, enrollment depended on the evaluating physician's completing a study form and obtaining an endocervical specimen. No method was in place during the study to ensure all physicians complied with performing one or both of these tasks. In addition, during the data collection portion of the study, the investigators discovered that several patients presenting to the ED for vaginal bleeding refused to allow a pelvic examination to be performed as part of their evaluation. Consequently, the evaluating emergency physician did not complete an informational data form. At least ten such cases were verbally reported to the investigators. However, since an informational data form for these patients was not completed by the physician, the total number of such cases is not known exactly.
Future research on this topic might include instituting a protocol in the ED to test all women pre-senting with vaginal bleeding for chlamydial and gonococcal cervical infection, followed by a determination of trends over time in the prevalence of recovery of these pathogens for that institution. In this way, a public health advantage might potentially be demonstrated for instituting such a protocol in other EDs. Future studies with greater patient enrollment may also be able to build upon the framework of clinical predictors of cervical infection included in Table 3 . This study lacks sufficient numbers to formulate reliable conclusions pertaining to clinical predictors of cervical infection.
CONCLUSIONS
In this inner-city population with a background cervical infection rate of approximately 18%, pregnant patients of less than 20 weeks' gestation and non-pregnant patients presenting to the ED with vaginal bleeding have similar prevalence rates of C. trachomatis and N. gonorrhoeae cervical infection. Endocervical swabs should be obtained from all women presenting to the ED with vaginal bleeding, regardless of pregnancy status, so that the need for antibiotic treatment in the ED or at follow-up, as well as the treatment of all sexual partners, may be well defined.
